Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) EPS (Weighted Average and Diluted) (2017 - 2025)

Historic EPS (Weighted Average and Diluted) for Champions Oncology (CSBR) over the last 13 years, with Q4 2025 value amounting to $0.02.

  • Champions Oncology's EPS (Weighted Average and Diluted) fell 6000.0% to $0.02 in Q4 2025 from the same period last year, while for Oct 2025 it was $0.17, marking a year-over-year increase of 38333.33%. This contributed to the annual value of $0.33 for FY2025, which is 16135.28% up from last year.
  • Per Champions Oncology's latest filing, its EPS (Weighted Average and Diluted) stood at $0.02 for Q4 2025, which was down 6000.0% from -$0.03 recorded in Q3 2025.
  • Over the past 5 years, Champions Oncology's EPS (Weighted Average and Diluted) peaked at $0.31 during Q1 2025, and registered a low of -$0.19 during Q3 2023.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.02 (2022), whereas its average is -$0.03.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 3002420.6% in 2021, then crashed by 1258310.28% in 2023.
  • Quarter analysis of 5 years shows Champions Oncology's EPS (Weighted Average and Diluted) stood at $0.02 in 2021, then tumbled by 105.91% to -$0.0 in 2022, then tumbled by 12583.1% to -$0.15 in 2023, then skyrocketed by 133.33% to $0.05 in 2024, then tumbled by 60.0% to $0.02 in 2025.
  • Its last three reported values are $0.02 in Q4 2025, -$0.03 for Q3 2025, and -$0.13 during Q2 2025.